Medigus Ltd Adr Stock Fundamentals
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Medigus Ltd ADR fundamentals help investors to digest information that contributes to Medigus' financial success or failures. It also enables traders to predict the movement of Medigus Stock. The fundamental analysis module provides a way to measure Medigus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigus stock.
Medigus |
Medigus Ltd ADR Company Return On Asset Analysis
Medigus' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medigus Return On Asset | -0.0663 |
Most of Medigus' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigus Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Medigus Ltd ADR has a Return On Asset of -0.0663. This is 99.24% lower than that of the Health Care Equipment & Supplies sector and 99.63% lower than that of the Health Care industry. The return on asset for all United States stocks is 52.64% lower than that of the firm.
Medigus Ltd ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medigus's current stock value. Our valuation model uses many indicators to compare Medigus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medigus competition to find correlations between indicators driving Medigus's intrinsic value. More Info.Medigus Ltd ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Medigus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Medigus Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigus' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medigus could also be used in its relative valuation, which is a method of valuing Medigus by comparing valuation metrics of similar companies.Medigus is currently under evaluation in return on asset category among its peers.
Medigus Fundamentals
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 65.3 M | |||
| Shares Outstanding | 1.89 M | |||
| Shares Owned By Institutions | 0.29 % | |||
| Number Of Shares Shorted | 4.18 K | |||
| Price To Earning | 33.86 X | |||
| Price To Book | 0.15 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 91.86 M | |||
| Gross Profit | 4.8 M | |||
| EBITDA | (11.99 M) | |||
| Net Income | (10.1 M) | |||
| Cash And Equivalents | 24.75 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 10.13 M | |||
| Debt To Equity | 0.27 % | |||
| Current Ratio | 1.38 X | |||
| Book Value Per Share | 18.67 X | |||
| Cash Flow From Operations | (5.66 M) | |||
| Short Ratio | 0.32 X | |||
| Earnings Per Share | (8.70) X | |||
| Number Of Employees | 77 | |||
| Beta | 1.37 | |||
| Market Capitalization | 4.13 M | |||
| Total Asset | 97.65 M | |||
| Retained Earnings | (85.59 M) | |||
| Working Capital | 14.63 M | |||
| Current Asset | 46.34 M | |||
| Current Liabilities | 7.23 M | |||
| Net Asset | 97.65 M |
About Medigus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medigus Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medigus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medigus Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |